Yellow Stem Enhances Distribution Agreement With Sweet Poison
Yellow Stem Enhances Distribution Agreement With Sweet Poison
Vancouver, British Columbia--(Newsfile Corp. - May 15, 2023) - Yellow Stem Tech Inc. (CSE: YY) ("Yellow Stem" or the "Company") is pleased to make the following announcements:
不列颠哥伦比亚省温哥华--(Newsfile Corp.-2023 年 5 月 15 日)- Yellow Stem Tech (CSE: YY)(“黄干” 或 “公司”)很高兴发布以下公告:
As disclosed in December, 2022, the Company signed both a Product Distribution Agreement (the "Distribution Agreement") and an Option Agreement with Sweet Poison Spirits S de RL de CV, a Mexican company headquartered in Guadalajara, Mexico, and Sweet Poison Spirits LLC, a California limited liability corporation headquartered in San Diego, California (collectively, "Sweet Poison"). The Distribution Agreement granted the Company the worldwide distribution rights to Sweet Poison's premium Tequila and Mezcal products under the "Sweet Poison" brand names for an initial period of ten years, renewable for a further ten years and beyond. The Option Agreement grants the Company the right to acquire Sweet Poison in the future for U.S. one million dollars.
正如2022年12月披露的那样,该公司与总部位于墨西哥瓜达拉哈拉的墨西哥公司Sweet Poispirits S de RL de CV和总部位于加利福尼亚州圣地亚哥的加州有限责任公司Sweet Poison Spirits LLC(统称 “Sweet Poison”)签署了产品分销协议(“分销协议”)和期权协议。分销协议授予该公司以 “Sweet Poison” 品牌名义在全球范围内分销Sweet Poison的优质龙舌兰酒和Mezcal产品的权利,最初为期十年,可再续十年及以后。期权协议授予公司将来以100万美元的价格收购Sweet Poison的权利。
The Company has now reached agreement with Sweet Poison, amending both the Distribution Agreement and the Option Agreement to include the acquisition of Sweet Poison's formula for one blend of Sweet Poison's tequila and four blends of mezcal. The Company can now more effectively execute its marketing plans, solidly backed by worldwide distribution rights to Sweet Poison spirits, and ownership of the proprietary formulas for the tequila and mezcal. The cost of acquiring the formulas will be deducted from the purchase price under the Option Agreement, in the event the Company exercises the option.
该公司现已与Sweet Poison达成协议,修订了分销协议和期权协议,将收购Sweet Poison的配方,用于一种混合Sweet Poison的龙舌兰酒和四种混合的梅斯卡尔酒。在Sweet Poison烈酒的全球分销权以及龙舌兰酒和梅斯卡尔酒专有配方的所有权的坚实支持下,该公司现在可以更有效地执行其营销计划。如果公司行使期权,则收购公式的成本将从期权协议下的购买价格中扣除。
In consideration for acquiring the formulas, the Company will issue to Sweet Poison a total of 2,500,000 post-consolidated shares at a deemed price of $0.10, with hold periods as follows:
作为收购公式的对价,公司将以0.10美元的认定价格向Sweet Poison发行总计2,500,000股合并后股票,持有期如下:
25% of the Shares will become free-trading four months following the date of issuance (the "Closing");
an additional 25% of the Shares will become free-trading 12 months following Closing;
an additional 25% of the Shares will become free-trading 18 months following Closing; and
the remaining 25% of the Shares will become free-trading 24 months following Closing.
25%的股票将在发行之日起四个月后进行自由交易(“收盘价”);
另有 25% 的股票将在收盘后12个月内实现自由交易;
另有 25% 的股票将在收盘后18个月内实现自由交易;以及
其余 25% 的股票将在收盘后24个月内实现自由交易。
A finder's fee of 250,000 post-consolidated shares will be issued related to this transaction for the finder's efforts in negotiating and facilitating the transaction, such shares to be restricted in the same manner as those shares to be issued to Sweet Poison.
将发行与本次交易相关的25万股合并后股票的发现费,用于发现者在谈判和促进交易方面的努力,此类股票的限制方式与向Sweet Poison发行的股票相同。
Name Change Proposed
提议更名
To demonstrate its commitment to the Sweet Poison goals and objectives, the Board of Directors has approved changing the Company's name from Yellow Stem Technologies Inc. to Sweet Poison Spirits Inc. The Company is proceeding with meeting all of the regulatory requirements related to a name change, and will confirm the effective date upon receipt of regulatory acceptance.
为了表明其对 Sweet Poison 目标和目的的承诺,董事会已批准将公司的名称从 Yellow Stem Technologies Inc. 更改为 甜毒烈酒公司。公司正在着手满足与更名有关的所有监管要求,并将在收到监管部门批准后确认生效日期。
Private Placement
私募配售
To meet the milestones and business objectives as disclosed in its Listing Statement as filed with the CSE and on SEDAR (see news release of March 28, 2023) the Company announces that it has arranged a non-brokered private placement of up to $1 million (the "Financing") through the issuance of up to 10 million units (the "Units") at a price of $0.10 per Unit. Each Unit will be comprised of one common share and one-half of one common share purchase warrant ("Warrant"), with each whole Warrant entitling the holder to purchase one common share at a price of $0.25 per share for a period of 24 months from closing, provided that, if after the expiry of all resale restrictions, the closing price of the Company's Shares is equal to or greater than $0.40 per share for 30 consecutive trading days, the Company may, by notice to the Warrant holders (which notice may be by way of general news release), reduce the remaining exercise period of the Warrants to not less than 30 days following the date of such notice.
实现向CSE和SEDAR提交的上市声明中披露的里程碑和业务目标(参见 2023 年 3 月 28 日的新闻稿)该公司宣布,它已安排了不超过100万美元的非经纪私募配售(“融资”),发行多达1000万个单位(“单位”),价格为每单位0.10美元。每个单位将由一股普通股和一份普通股购买权证(“认股权证”)的一半组成,每份完整认股权证使持有人有权在收盘后的24个月内以每股0.25美元的价格购买一股普通股,前提是,如果在所有转售限制到期后,公司股票的收盘价连续30个交易日等于或大于每股0.40美元,则公司可以:通过向认股权证持有人发出通知(该通知可能是通过一般新闻稿的方式),减少剩余的行使认股权证的有效期至该通知发出之日起不少于30天。
The Company may pay finders' fees of up to 8% in cash and 8% in half warrants for subscriptions attributable to finders. Finders' warrants will be valid for a period of two years, with each warrant exercisable on the same terms as the Warrants sold under the Financing.
对于归属于发现者的认购,公司可能以现金支付高达8%的发现者费用和8%的半额认股权证。发现者认股权证的有效期为两年,每份认股权证的行使条件与根据融资出售的认股权证相同。
The net proceeds of the Financing will be budgeted as follows:
融资的净收益将按以下方式编入预算:
Use of Funds | Amount (C$) |
Costs associated with regulatory filings and related approvals | 50,000 |
Formulation of initial marketing and distribution plans | 50,000 |
Costs related to signing up distribution agents in North & South America and Europe. | 50,000 |
Purchase of initial inventory for distribution (excluding sales) | 500,000 |
G & A expenses | 164,000 |
Costs of financing | 80,000 |
Working Capital | 106,000 |
Total | $1,000,000 |
资金的使用 | 金额 (加元) |
与监管申报和相关批准相关的成本 | 5万个 |
制定初步的营销和分销计划 | 5万个 |
与在北美、南美和欧洲注册分销代理商有关的成本。 | 5万个 |
购买初始库存进行分销(不包括销售) | 50 万 |
G&A 费用 | 164,000 |
融资成本 | 8000 |
营运资金 | 106,000 |
总计 | 1,000,000 美元 |
There is no material fact or material change about the Company that has not been generally disclosed.
本公司没有未被普遍披露的重大事实或重大变化。
About Sweet Poison Spirits:
关于甜毒精灵:
Sweet Poison Spirits are creators and distributors of premium quality spirits. The company is committed to respecting traditional and ancestral processes, sustainability and the environment. For more on Sweet Poison, visit .
Sweet Poison Spirits 是优质烈酒的创造者和分销商。公司致力于尊重传统和祖先的工艺、可持续发展和环境。有关 Sweet Poison 的更多信息,请访问。
ON BEHALF OF THE BOARD
代表董事会
(Sgd.) "Robert Eadie"
Robert Eadie, President, Chief Executive Officer and Director
(Sgd.)“Robert Eadie”
罗伯特·伊迪,总裁、首席执行官兼董事
FOR FURTHER INFORMATION PLEASE CONTACT:
Telephone: 1-604-602-4935 Facsimile: 1-604-602-4936
Contact: Robert Eadie
欲了解更多信息,请联系:
电话:1-604-602-4935 传真:1-604-602-4936
联系人:Robert Eadie
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
加拿大证券交易所及其监管服务提供商(该术语在加拿大证券交易所的政策中定义)均不对本新闻稿的充分性或准确性承担责任。
Certain statements and information herein, including all statements that are not historical facts, contain forward-looking statements and forward-looking information within the meaning of applicable securities laws. Such forward-looking statements or information include but are not limited to statements or information with respect to closing of agreements and future operations.
此处的某些陈述和信息,包括所有非历史事实的陈述,包含适用证券法所指的前瞻性陈述和前瞻性信息。此类前瞻性陈述或信息包括但不限于与协议达成和未来运营有关的陈述或信息。
Forward-looking statements and information by their nature are based on assumptions and involve known and unknown risks, uncertainties and other factors which may cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements or information. There is no assurance the Company will be able to execute its distribution plans profitably, or at all. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws.
就其性质而言,前瞻性陈述和信息基于假设,涉及已知和未知的风险、不确定性和其他因素,这些因素可能导致公司的实际业绩、业绩或成就与此类前瞻性陈述或信息所表达或暗示的任何未来业绩、业绩或成就存在重大差异。无法保证该公司能够以盈利方式或根本无法保证其分配计划。除非根据适用的证券法,否则公司不承诺更新任何前瞻性信息。
To view the source version of this press release, please visit
要查看本新闻稿的源版本,请访问